Doctors administer Botox all the time for everything from lazy eye to bladder dysfunction
100023.DOI
While there have been shortages of GLP-1s, Lilly and Novo Nordisk have also built up production and distribution capacity, achieving economies of scale
up to 56 days , but refrigeration is recommended
Emotional and Psychological Factors Our relationship with food often runs beyond biology
Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively
